Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s Why

Shares of Hypermarcas (OTCMKTS:HYPMY – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $4.3215, but opened at $4.05. Hypermarcas shares last traded at $4.05, with a volume of 270 shares changing hands.

Hypermarcas Stock Performance

The firm’s fifty day simple moving average is $4.48 and its 200 day simple moving average is $4.52. The company has a market capitalization of $2.57 billion, a price-to-earnings ratio of 17.61 and a beta of 0.73. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.99%. The business had revenue of $408.83 million during the quarter.

Hypermarcas Company Profile

(Get Free Report)

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

Further Reading

• Five stocks we like better than Hypermarcas
• What Are Dividend Achievers? An Introduction
• Western Digital’s Nasdaq-100 Entry Caps Its AI-Driven Comeback
• Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
• Paramount Threw a Wrench in Netflix’s Bid to Acquire Warner Bros.
• What Are the U.K. Market Holidays? How to Invest and Trade
• 3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most